Keywords: CNS; central nervous system; ERT; Enzyme replacement therapy; HCT; hematopoietic cell transplantation; MPS; Mucopolysaccharidosis; MPS I; Mucopolysaccharidosis Type I; MPS IH; Mucopolysaccharidosis Type IH, Hurler Syndrome; MRI; magnetic resonance imaging
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: DBS; Dried blood spot; GAA; Acid α-glucosidase; GBA; Acid β-d-glucosidase; GLA; Acid α-galactosidase; IDUA; Acid α-l-iduronidase; LSD; Lysosomal storage disorder; MPS I; Mucopolysaccharidosis type I; MSPHL; Missouri State Public Health Laboratory; NBS
Keywords: DBS; Dried blood spots collected on filter paper; MPS I; Mucopolysaccharidosis type I; MPS VI; Mucopolysaccharosis type VI; LSDs; Lysosomal storage disorders; LC/MS/MS; Liquid chromatography combined with tandem mass spectrometry; GAL; Alpha-galactosidase
Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling
Keywords: IEM; inborn errors of metabolism; LSD; lysosomal storage diseases; MPS; mucopolysaccharidoses; GAGs; glycosaminoglycans; MPS I; mucopolysaccharidosis type I; MPS IT; treated mucopolysaccharidosis type I; UPLC-IM-MS; ultraperformance liquid chromatography-
Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management
Keywords: CNS; Central nervous system; DBS; Dried blood spot; ERT; Enzyme replacement therapy; GAG; Glycosaminoglycan; HSCT; Hematopoietic stem cell transplantation; IDUA; α-L-iduronidase; MPS; Mucopolysaccharidoses; MPS I; Mucopolysaccharidosis type I; MRI; Magne
Neonatal tolerance induction enables accurate evaluation of gene therapy for MPS I in a canine model
Keywords: AAV; Gene therapy; Intrathecal; MPS I; Neonatal tolerance;
Original ArticlesOutcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I
Keywords: MPS I; mucopolysaccharidosis type I; enzyme replacement therapy; laronidase; 6MWT; 6-minute walk test; ERT; Enzyme replacement therapy; FVC; Forced vital capacity; GAG; Glycosaminoglycan; MPS I; Mucopolysaccharidosis type I; uGAG; Urinary glycosaminoglyca
Obstructive sleep apnea syndrome after hematopoietic stem cell transplantation in children with mucopolysaccharidosis type I
Keywords: OSAS; obstructive sleep apnea syndrome; MPS I; mucopolysaccharidosis I; HSCT; hematopoietic stem cell transplantation; PSG; polysomnography; AHI; apnea-hypopnea index; GAG; glycosaminoglycan; IDUA; a-L-iduronidase; MPS I-H; Hurler syndrome; MPS I-S; Sch
PEGylated cationic nanoemulsions can efficiently bind and transfect pIDUA in a mucopolysaccharidosis type I murine model
Keywords: Cationic nanoemulsions; DSPE-PEG; MPS I; Plasmid; pIDUA;
Identification of mucopolysaccharidosis I heterozygotes based on biochemical characteristics of L-iduronidase from dried blood spots
Keywords: MPS I; mucopolysaccharidosis I; IDUA; L-iduronidase; LSD; lysosomal storage diseases; DBS; dried blood spots; 4-MU-ID; 4-methylumbelliferyl-α-L-iduronide; TCA; trichloroacetic acid; 4-MU; 4-methylumbelliferone; Lysosomal storage diseases; MPS I; IDUA; Dr
Agile delivery of protein therapeutics to CNS
Keywords: Aβ; amyloid β; Ab-InsR; antibodies against insulin receptor; Ab-TfR; antibodies against transferrin receptor; AD; Alzheimer's disease; Aerosol OT; bis-(2-ethylhexyl) sulfosucciate; ALS; amyotrophic lateral sclerosis; ApoB; apolipoprotein B; ApoE; apolip
An exploratory study of brain function and structure in mucopolysaccharidosis type I: Long term observations following hematopoietic cell transplantation (HCT)
Keywords: MPS I; Hematopoietic cell transplant; Attention span; Cognition; Diffusion tensor imaging; Medical history;
Educational Corner of the Issue
Keywords: Mucopolysaccharidosis type I; MPS I; Lysosomal enzyme; Lysosomal storage disorder; Facial dysmorphism;
A novel mucopolysaccharidosis type I associated splice site mutation and IDUA splice variants
Keywords: Cq; quantification cycles; DS; dermatan sulfate; ERT; enzyme replacement therapy; GAGs; glycosaminoglycans; HSCT; hematopoietic stem cell transplantation; HS; heparan sulfate; IDUA; α-l-iduronidase; MPS I; mucopolysaccharidosis type I; PTC; premature ter
Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI
Keywords: Mucopolysaccharidosis; Dermatan sulfate; Heparan sulfate; High-risk screening; Urine; Liquid chromatography-tandem mass spectrometry; LC-MS/MS; MPS I; MPS II, MPS VI; Biomarker
Rapid and accurate denaturating high performance liquid chromatography protocol for the detection of α-l-iduronidase mutations causing mucopolysaccharidosis type I
Keywords: Mucopolysaccharidosis type I; MPS I; α-l-Iduronidase; IDUA; dHPLC
Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation
Keywords: MPS I; Hurler syndrome; Mouse; W402X mutation; α-l-iduronidase
Characterization of Surgical Procedures in Patients with Mucopolysaccharidosis Type I: Findings from the MPS I Registry
Keywords: CNS; Central nervous system; ERT; Enzyme replacement therapy; HSCT; Hematopoietic stem cell transplantation; MPS I; Mucopolysaccharidosis type I;
Guidelines for the Management of Mucopolysaccharidosis Type I
Keywords: ADLs; Activities of daily living; ATR; Abdominal thorax rebalance; BAEP; Brain stem auditory evoked potential; BHM; Bronchial hygiene maneuvers; BMT; Bone marrow transplant; CFP; Federal Psychology Council; CH; Communicating hydrocephalus; CHF; Congestive
Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and mice
Keywords: FIX; Factor IX; IV; intravenous; hFIX; human FIX; RV; retroviral vector; MPS I; mucopolysaccharidosis I; CTL; cytotoxic T lymphocyte; cIDUA; canine α-l-iduronidase; WPRE; woodchuck hepatitis virus post-transcriptional regulatory element; IU; internationa